MCL1 and lung carcinoma: In lung cancer, miR-133b expression is largely reduced compared to adjacent normal tissues and studies have shown that miR-133b targets the 3′ UTR of both MCL1 and BCLW and promotes gemcitabine-induced apoptosis [117].